CIS Pharma is a pharmaceutical research company. We are innovators discovering New Chemical Entities, Drug Delivery Systems and Medical Devices having a strong scientific and commercial rationale. Applying innovative chemistry CIS Pharma develops novel, target-specific treatments to improve patient care and address unmet medical needs. CIS Pharma patents and licenses-out its pipeline products to advance them through regulatory approval. In co-operation with its development partners CIS Pharma offers the full range of chemistry services from lab scale synthesis up to commercial cGMP manufacturing of active pharmaceutical ingredients. The offered Cellophil™ biomedical polymer technology has a wide range of applications. Our vision is to set a new gold standard in the field of biomedical polymers within the next 5 years.

Our strategy is to partner with industry / investors to develop our innovations into commercially viable technologies. Consequently we offer licenses for the development, manufacturing and distribution of our innovations. With regards to Cellophil we are looking for partners with a strong (polymer) development and sales platform. We provide cGMP-manufacturing of monomers as well as regulatory support for DMF filing. With established proof of concept Cellophil's physical and chemical properties are to be tailored to the specific needs of the application.

To view this information, you must subscribe to Partneringtools.

To view this information, you must subscribe to Partneringtools.

To view this information, you must subscribe to Partneringtools.